Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Finished Goods (2019 - 2022)

Marimed (MRMD) has disclosed Finished Goods for 4 consecutive years, with $5.3 million as the latest value for Q1 2022.

  • Quarterly Finished Goods rose 70.88% to $5.3 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $5.3 million through Mar 2022, up 70.88% year-over-year, with the annual reading at $3.8 million for FY2021, 35.17% up from the prior year.
  • Finished Goods for Q1 2022 was $5.3 million at Marimed, up from $3.8 million in the prior quarter.
  • The five-year high for Finished Goods was $5.8 million in Q3 2021, with the low at $518166.0 in Q4 2019.
  • Average Finished Goods over 4 years is $3.8 million, with a median of $3.8 million recorded in 2021.
  • The sharpest move saw Finished Goods skyrocketed 446.82% in 2020, then soared 35.17% in 2021.
  • Over 4 years, Finished Goods stood at $518166.0 in 2019, then surged by 446.82% to $2.8 million in 2020, then skyrocketed by 35.17% to $3.8 million in 2021, then skyrocketed by 37.47% to $5.3 million in 2022.
  • According to Business Quant data, Finished Goods over the past three periods came in at $5.3 million, $3.8 million, and $5.8 million for Q1 2022, Q4 2021, and Q3 2021 respectively.